Scharf Investments, LLC Novartis Ag Transaction History
Scharf Investments, LLC
- $3.09 Billion
- Q4 2025
A detailed history of Scharf Investments, LLC transactions in Novartis Ag stock. As of the latest transaction made, Scharf Investments, LLC holds 962,900 shares of NVS stock, worth $127 Million. This represents 4.1% of its overall portfolio holdings.
Number of Shares
962,900
Previous 1,210,948
20.48%
Holding current value
$127 Million
Previous $155 Million
18.43%
% of portfolio
4.1%
Previous 4.62%
Shares
35 transactions
Others Institutions Holding NVS
# of Institutions
1,625Shares Held
136MCall Options Held
1.53MPut Options Held
2.22M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...